Abstract
The unprecedented scientific achievements in combating the COVID-19 pandemic reflect a global response informed by unprecedented access to data. We now have the ability to rapidly generate a diversity of information on an emerging pathogen and, by using high-performance computing and a systems biology approach, we can mine this wealth of information to understand the complexities of viral pathogenesis and contagion like never before. These efforts will aid in the development of vaccines, antiviral medications, and inform policymakers and clinicians. Here we detail computational protocols developed as SARS-CoV-2 began to spread across the globe. They include pathogen detection, comparative structural proteomics, evolutionary adaptation analysis via network and artificial intelligence methodologies, and multiomic integration. These protocols constitute a core framework on which to build a systems-level infrastructure that can be quickly brought to bear on future pathogens before they evolve into pandemic proportions.
Original language | English |
---|---|
Title of host publication | Methods in Molecular Biology |
Publisher | Humana Press Inc. |
Pages | 317-351 |
Number of pages | 35 |
DOIs | |
State | Published - 2022 |
Publication series
Name | Methods in Molecular Biology |
---|---|
Volume | 2452 |
ISSN (Print) | 1064-3745 |
ISSN (Electronic) | 1940-6029 |
Funding
This research funded by the Laboratory Directed Research and Development and Seed funding programs of Oak Ridge National Laboratory (LOIS:10074,10124) and the DOE Office of Science through the National Virtual Biotechnology Laboratory (NVBL), a consortium of DOE national laboratories focused on response to COVID-19, with funding provided by the Coronavirus CARES Act. This research used resources of the Oak Ridge Leadership Computing Facility (OLCF) and the Compute and Data Environment for Science (CADES) at the Oak Ridge National Laboratory, which is supported by the Office of Science of the U.S. Department of Energy under Contract No. DE-AC05-00OR22725. Figures were generated with Biorender and VMD. Erica T. Prates and Michael R. Garvin contributed equally to this work. Author Contributions: Erica Prates (Conceptualization, Investigation, Methodology, Visualization, Writing—original draft, review and editing), Michael Garvin (Conceptualization, Investigation, Methodology, Visualization, Writing——original draft, review and editing), Piet Jones (Investigation, Methodology, Writing— original draft, review and editing, visualization), J. Izaak Miller (Writing—original draft, Writing—review and editing), Kyle A. Sullivan (Investigation, Writing—original draft, Writing— review and editing), Ashley Cliff (Investigation, Methodology, Writing—original draft, Writing—review and editing), Joao Gabriel Felipe Machado Gazolla (Investigation, Methodology, Visualization, Writing—original draft, Writing—review and editing), Man-esh Shah (Investigation, Methodology, Writing—original draft, review and editing), Angelica M. Walker (Investigation, Methodology, Writing—original draft, review and editing), Matthew Lane (Investigation, Methodology, Writing—original draft, review and editing), Christopher Rentsch (Investigation, Methodology, Writing—original draft, review and editing), Amy Justice (Investigation, Methodology, Writing—original draft, review and editing), Mirko Pavicic (Writing—original draft, review and editing), Jona-thon Romero (Investigation, Methodology, Writing—original draft, review and editing), Daniel Jacobson (Conceptualization, Formal Analysis, Funding acquisition, Methodology, Supervision, Writing—original draft, Writing—review and editing). This work was also funded by the United States Government.
Funders | Funder number |
---|---|
Compute and Data Environment for Science | |
National Virtual Biotechnology Laboratory | |
United States Government | |
U.S. Department of Energy | DE-AC05-00OR22725 |
Office of Science | |
Oak Ridge National Laboratory | |
Laboratory Directed Research and Development |
Keywords
- Antiviral
- COVID-19
- Multiomics
- Pandemic
- SARS-CoV-2
- Systems Biology